Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3) is a human pseudogene related in sequence to the solute carrier family 20 phosphate transporter (SLC20A1), but it does not encode a functional protein and is generally considered non-functional in terms of protein-coding capacity[1][3][7][9]. Pseudogenes such as SLC20A1P3 arise via gene duplication or retrotransposition events but accumulate disabling mutations such as premature stop codons or frameshifts, which prevent them from producing a functional protein product[9]. Although pseudogenes can sometimes act as regulators by producing non-coding RNAs that impact the expression of other genes, there is currently no evidence that SLC20A1P3 has such a regulatory, pathological, or therapeutic role[4][7]. Consequently, it is not considered a therapeutic target, nor are there known interacting drugs, mechanisms of action, or safety concerns[3][7]. There are no known roles for SLC20A1P3 in disease, drug action, or biomarker use[3][7]. No structured gene ontology functions or pathway data are available for this gene[7]. Conclusion: SLC20A1P3 is a pseudogene, not a functional target or druggable protein, and lacks evidence for use in therapeutics, biomarker development, or disease association. The inclusion of "pseudogene" and lack of functional annotation mean it is not considered a proper molecular target for therapeutics[3][7][9].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3).